drugset / Trial / NCT02373579

Effect of Omega-3 Fatty Acids on Methotrexate Induced Hepatotoxicity in Children With Acute Lymphoblastic Leukemia

NCT02373579

Phase 2 Completed 70 enrolled Nancy Samir Elbarbary
RandomizedParallel-groupOpen-labelSupportive care

Summary

Study the role of oxidative stress in methotrexate induced hepatic damage, and the possible protective effect of OMEGA-3 fatty acids against methotrexate hepatotoxicity using clinical and biochemical parameters.

Timeline

Start
2012-06
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Omega-3 fatty acids Unknown 1000 mg Oral
Comparator Methotrexate Small molecule 20 mg/m2 Oral